GPR119 Agonists, a Novel Approach for the Treatment of Type 2 Diabetes

Folia Pharmacologica Japonica - Japan
doi 10.1254/fpj.136.259
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors With Core Hopping Approach

PLoS ONE
Multidisciplinary
2012English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

Gene Therapy for Type 1 Diabetes: A Novel Approach for Targeted Treatment of Autoimmunity

Journal of Clinical Investigation
Medicine
2004English

Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus

Baylor University Medical Center Proceedings
Medicine
2006English

Novel Approaches to the Treatment of Hyperglycaemia in Type 2 Diabetes Mellitus

Internal Medicine Journal
Internal Medicine
2016English

Exploring Treatment Strategies for Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus

Enzyme Engineering
2015English

Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Metformin Remains the Best Treatment for Type 2 Diabetes

BMJ
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy